Related Experiment Video
Updated: May 13, 2025

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
Congenital hyperinsulinemic hypoglycaemia in a neonate: a rare homozygous ABCC8 gene mutation
Chandra Prabha1, Shalini Tripathi2, Arpita Bhriguvanshi2
1Pediatrics, King George's Medical University, Lucknow, Uttar Pradesh, India dr.chandraprabha9@gmail.com.
Insights
Congenital hyperinsulinism (CHI) is a rare cause of persistent hyperinsulinemic hypoglycemia in infants. Genetic diagnosis and timely management, including octreotide and cornstarch, are crucial for preventing neurological issues.
Area of Science:
- Pediatric Endocrinology
- Medical Genetics
- Neonatology
Background:
- Hyperinsulinemic hypoglycemia (HH) is a serious condition in neonates and infants.
- Congenital hyperinsulinism (CHI) arises from genetic defects in pancreatic beta-cells, affecting KATP channels.
- ABCC8 and KCNJ11 are key genes implicated in CHI.
Purpose of the Study:
- To present a case of congenital hyperinsulinism in a neonate.
- To highlight the diagnostic and therapeutic challenges and outcomes.
- To emphasize the importance of genetic testing and tailored management.
Main Methods:
- Clinical case presentation of a neonate with persistent hypoglycemia.
- Genetic analysis identifying a homozygous pathogenic variant in the ABCC8 gene.
- Management strategies including glucose infusions, diazoxide, octreotide, and cornstarch therapy.
Main Results:
- A neonate diagnosed with CHI due to a homozygous ABCC8 variant (c.4253G>A, p.Arg1418His).
- Initial refractoriness to standard treatments.
- Successful response to octreotide therapy, cornstarch, and careful feeding regimen, avoiding surgery.
Conclusions:
- Genetic diagnosis is essential for identifying the cause of congenital hyperinsulinism.
- Timely and individualized management, including novel therapeutic approaches, can prevent severe complications.
- This case highlights the efficacy of octreotide and cornstarch in managing refractory CHI.
Abstract:
Hyperinsulinemic hypoglycaemia (HH) is a heterogeneous disorder causing persistent hypoketotic hypoglycaemia in neonates and infants. Congenital hyperinsulinism (CHI) is a rare cause of HH, resulting from inappropriate insulin secretion by pancreatic β-cells due to genetic defects in key genes, notably ABCC8 and KCNJ11, which encode the SUR1 and Kir6.2 components of the KATP channels, respectively. We present a case of a neonate with congenital HH with persistent hypoglycaemia since birth, which was managed with high-dose glucose infusions, diazoxide and octreotide. A homozygous pathogenic missense variant, c4253G>A (p.Arg1418His) in Exon 35 of the ABCC8 gene was identified in the neonate, confirming CHI. Despite initial refractoriness to treatment, the infant responded to octreotide therapy, cornstarch and careful management with regular feeds and monitoring, avoiding the need for surgical intervention. This case underscores the critical role of genetic diagnosis and timely management in preventing long-term neurological sequelae.
More Related Videos
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
Related Concept Videos
Inborn Errors of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypoglycemia and Glucagon
Diabetes Mellitus: Type 2 and Gestational